#GenomeMedicine
Recommendations for bioinformatics in clinical practice. #Bioinformatics #ClinicalBioinformatics #BestPractices #GenomeMedicine 🧪🧬 🖥️
genomemedicine.biomedcentral.com/articles/10....
October 27, 2025 at 6:06 PM
🧬New approach to decoding mutational signatures improves prediction of prognosis in #OvarianCancer.

📰 #GenomeMedicine ✍️ Patricia Ferrer-T Iván Galván-F & @fransupek.bsky.social

➡️ bit.ly/4nA579b 📌DOI: 10.1186/s13073-025-01497-7

@genomedatalab.bsky.social @bric-ucph.bsky.social

🧪
July 8, 2025 at 10:50 AM
Novel approach to decoding mutational signatures improves prediction of prognosis in #OvarianCancer

📝 New paper published in #GenomeMedicine by researchers from @irbbarcelona.org & BRIC Copenhagen

#BISTCommunity #CancerResearch

➡️ bist.eu/new-approach...
July 9, 2025 at 6:14 PM
Microbiome-based therapeutics towards healthier aging and longevity. #Mibrobiome #Aging #MicrobiomeTherapeutics #GenomeMedicine 🧪
genomemedicine.biomedcentral.com/articles/10....
July 7, 2025 at 8:32 AM
Excited to share our latest study of the PTSD prefrontal cortex out @GenomeMedicine. rdcu.be/ejZ3T
Our systems biology approach established a brain multi-omic, multi-region analysis comprising individuals with PTSD and MDD
A multi-omic approach implicates novel protein dysregulation in post-traumatic stress disorder
rdcu.be
April 30, 2025 at 2:24 PM
Published in #GenomeMedicine, the method improves predictions of survival in #OvarianCancer and may also apply to other tumour types.

📌DOI: 10.1186/s13073-025-01497-7
July 8, 2025 at 10:50 AM
A large-scale GWAS study reveals a new TB susceptibility locus across 4 population… PMID:42192477, Genome Med 2026, @GenomeMedicine @OTSociety @NAR_Open https://doi.org/10.1186/s13073-026-01670-6 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Genome-wide association study reveals a novel tuberculosis susceptibility locus in multiple East Asian and European populations | Genome Medicine | Springer Nature Link
Tuberculosis (TB) continues to be a leading cause of morbidity and mortality worldwide. Although numerous genome-wide association studies (GWAS) have explo
doi.org
May 31, 2026 at 4:10 AM
AI-designed OpenCRISPR-1 offers enhanced genome editing, outperforming Cas9 with h… PMID:42192532, Genome Med 2026, @GenomeMedicine @OTSociety @NAR_Open https://doi.org/10.1186/s13073-026-01682-2 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
High-fidelity genome and prime editing enabled by the AI-designed openCRISPR-1 | Genome Medicine | Springer Nature Link
RNA-guided nucleases such as CRISPR-Cas9 systems have revolutionized genome engineering by enabling programmable DNA modifications. Although structure-guid
doi.org
May 31, 2026 at 5:10 AM
An important paper on Macrophage-#MuscleStemCell crosstalks in regenerative dynamics of ischemic #SkeletalMuscle #CriticalLimbThreateningIschemia

Proinflammatory niche perturbs MuSC proliferation-differentiation in #LimbIschemia

#GenomeMedicine 2023
genomemedicine.biomedcentral.com/articles/10....
March 26, 2024 at 7:09 PM
Genome Medicine study: siRNAs showed activity against all 5 human betacoronaviruses. Antivirals now only target SARS-CoV-2. PMID:42015182, Genome Med 2026, @GenomeMedicine @OTSociety @NAR_Open https://doi.org/10.1186/s13073-026-01659-1 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Comparative genomics identifies small interfering RNA with activity against all five human betacoronaviruses | Genome Medicine | Springer Nature Link
The Orthocoronavirinae virus subfamily (CoV) poses a continuous global health threat. Seven CoV species are known to infect humans and additional animal Co
doi.org
May 24, 2026 at 2:40 PM
MetroSCREEN pinpoints metabolic drivers in the tumor microenvironment, decoding reaction-level changes across 100s of cancer types. PMID:41420243, Genome Med 2025, @GenomeMedicine @OTSociety @NAR_Open https://doi.org/10.1186/s13073-025-01572-z #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
https://doi.org/10.1186/s13073-025-01572-z
No description available
doi.org
January 9, 2026 at 1:10 PM
www.uksh.de
September 25, 2025 at 9:35 AM
Studying 101 Klebsiella pneumoniae CG147 strains & 911 genomes reveals CRISPR-Cas/anti-CRISPR's role in antimicrobial resistance. #MDRKBP PMID:39885543, Genome Med 2025, @GenomeMedicine @OTSociety https://doi.org/10.1186/s13073-025-01428-6 #Medsky 🧪
Intricate interplay of CRISPR-Cas systems, anti-CRISPR proteins, and antimicrobial resistance genes in a globally successful multi-drug resistant Klebsiella pneumoniae clone | Genome Medicine | Full Text
Klebsiella pneumoniae is one of the most prevalent pathogens responsible for multiple infections in healthcare settings and the community. K. pneumoniae CG147, primarily including ST147 (the founder ST), ST273, and ST392, is one of the most globally successful MDR clone linked to various carbapenemases. One hundred and one CG147 strains were sequenced and additional 911 publicly available CG147 genome sequences were included for analysis. The molecular epidemiology, population structure, and time phylogeny were investigated. The virulome, resistome, and mobilome were analyzed, and the recombination in the capsular region was studied. The CRISPR-Cas and anti-CRISPR were identified. The interplay between CRISPR-Cas, anti-CRISPR, and carbapenemase-encoding plasmids was analyzed and experimentally validated. We analyzed 1012 global CG147 genomes, with 80.4% encoding at least one carbapenemase (NDM [529/1012, 52.3%], OXA-48-like [182/1012, 17.7%], and KPC [105/1012, 10.4%]). Surprisingly, a
doi.org
March 9, 2025 at 10:00 AM
Our latest work on PAM is out #GenomeMedicine

We show that PAM-T2D risk alleles result in "GLP-1 resistance".

I am so proud of this collaborative work championed by two incredible early career academics - Mahesh Umpathysivam & Elisa Araldi (not on BlueSky)
link.springer.com/article/10.1...
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists - Genome Medicine
Genome Medicine - Type 2 diabetes (T2D) is a leading cause of morbidity and mortality worldwide. Despite the availability of multiple glucose-lowering agents, only half of individuals with T2D...
link.springer.com
April 13, 2026 at 10:25 PM
CRISPR-Cas9 improves gene discovery but faces challenges in variant cell lines like cancer due to reference genome discrepancies. A genome-aware approach boosts target validation and screen accuracy. PMID:39593080, Genome Med 2024, @GenomeMedicine
Genome-aware annotation of CRISPR guides validates targets in variant cell lines and enhances discovery in screens - Genome Medicine
Background CRISPR-Cas9 technology has revolutionised genetic screens and can inform on gene essentiality and chemo-genetic interactions. It is easily deployed and widely supported with many pooled CRISPR...
buff.ly
January 26, 2025 at 6:47 AM
ERG regulates endothelial plasticity, crucial for vascular homeostasis. Its loss leads to mesenchymal transition—key in diseases. PMID:42067854, Genome Med 2026, @GenomeMedicine @OTSociety @NAR_Open https://doi.org/10.1186/s13073-026-01638-6 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
ERG is a regulator of dynamic and reversible endothelial plasticity | Genome Medicine | Springer Nature Link
Endothelial cells (ECs) orchestrate vascular homeostasis and resilience but can undergo reprogramming into a mesenchymal-like phenotype through an endothel
doi.org
May 28, 2026 at 10:10 AM
Congratulations on the publication of the paper “Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with IBD across disease stages” by Prof. Franke, led by Dr. Mahdy and Dr. ElAbd.
link.springer.com/article/10.1...
#genomemedicine #tcells #IBD
January 9, 2026 at 12:21 PM
New CRISPR tool models gene expression to refine sgRNA design, predicting knockout success. Unlike others, it factors in conservation, amino acid, frameshifts. PMID:39716183, Genome Med 2024, @GenomeMedicine
A tool for CRISPR-Cas9 sgRNA evaluation based on computational models of gene expression - Genome Medicine
Background CRISPR is widely used to silence genes by inducing mutations expected to nullify their expression. While numerous computational tools have been developed to design single-guide RNAs (sgRNAs)...
buff.ly
January 26, 2025 at 6:46 AM
Exciting updates from HGVS Nomenclature 2024! Boosts in governance, community engagement, and usability with HVNC now aligned under HUGO. Enhanced web functionality. #genomics #dna #innovation PMID:39702242, Genome Med 2024, @GenomeMedicine doi.org/10.1186/s130...
HGVS Nomenclature 2024: improvements to community engagement, usability, and computability - Genome Medicine
Background The Human Genome Variation Society (HGVS) Nomenclature is the global standard for describing and communicating variants in DNA, RNA, and protein sequences in clinical and research genomics....
doi.org
December 27, 2024 at 12:11 AM
Discover how SiRCle model integration reveals regulatory mechanisms in renal cancer. Explore ccRCC's epigenome, transcriptome & more for tailored therapies! 🚀 #CancerResearch PMID:39633487, Genome Med 2024, @GenomeMedicine
SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer - Genome Medicine
Background Clear cell renal cell carcinoma (ccRCC) tumours develop and progress via complex remodelling of the kidney epigenome, transcriptome, proteome and metabolome. Given the subsequent tumour and...
buff.ly
January 26, 2025 at 6:46 AM
#MECP2 Duplication Syndrome shows no clear link between DNA rearrangements and symptoms, despite duplication size & complexity. 38% of families have complex genomics. #Neurodevelopment PMID:39696717, Genome Med 2024, @GenomeMedicine doi.org/10.1186/s130...
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression - Genome Medicine
Background MECP2 Duplication Syndrome, also known as X-linked intellectual developmental disorder Lubs type (MRXSL; MIM: 300260), is a neurodevelopmental disorder caused by copy number gains spanning ...
doi.org
December 26, 2024 at 3:17 AM
Just read @BMCBiology is considering a co-submission process w @GenomeBiology or @GenomeMedicine ... wonder if this is a start of journal review reform?
November 25, 2024 at 12:49 AM
2️⃣ The second paper developes a tool to classify pancreatic cancer subtypes, to help determine the best treatment and drive research forward. It can be used through a web page or as an app.
First author: @PVilloslada , published in GenomeMedicine @bmc.springernature.com 👇
January 13, 2026 at 11:56 AM